VEGFA and age-related macular degeneration: While the introduction of anti-angiogenesis therapeutic strategies (anti-VEGF) has brought a significant advancement in the stabilization and management of wet AMD [8], currently there is no available treatment for dry AMD being responsible for most AMD cases.